Literature DB >> 15023159

Glomerular enlargement assessed by paired donor and early protocol renal allograft biopsies.

Gabriela Alperovich1, Rafael Maldonado, Francesc Moreso, Xavier Fulladosa, Josep M Grinyó, Daniel Serón.   

Abstract

The aim of the study was to evaluate the evolution of glomerular volume 4 months after transplantation. Mean glomerular volume (Vg) was estimated according to the Weibel and Gomez method in a donor and a protocol biopsy done at 139 +/- 58 d in 41 stable grafts. Biopsies were also evaluated according to the Banff schema. Vg increased after transplantation from 4.1 +/- 1.4 to 5.1 +/- 2.4 x 10(6) micro3 (p=0.02). In patients with chronic allograft nephropathy in the protocol biopsy (n=14), the Vg enlargement was -0.3 +/-x 10(6) micro3 while in patients without chronic allograft nephropathy (n=27), glomerular enlargement was 1.6 +/- 2.1 x 10(6) micro3 (p=0.01). There was a negative association between glomerular volume in the donor biopsy and glomerular enlargement after transplantation (R=- 0.34, p=0.03). Multivariate regression analysis confirmed that Vg in the donor biopsy and chronic allograft nephropathy in the protocol biopsy were independent predictors of glomerular enlargement after transplantation (R=0.48, p=0.01). Moreover, Vg in the protocol biopsy correlated with creatinine clearance at the time of biopsy (R=0.38, p=0.01). Glomeruli enlarge after transplantation and glomerular volume after 4 months correlates with creatinine clearance, suggesting that glomerular enlargement is a necessary condition for renal adaptation to the recipient. Glomerular enlargement is impaired in patients with chronic allograft nephropathy.

Entities:  

Mesh:

Year:  2004        PMID: 15023159     DOI: 10.1111/j.1600-6143.2004.00392.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function.

Authors:  Abhijit S Naik; Farsad Afshinnia; Jawad Aqeel; Diane M Cibrik; Milagros Samaniego; Larysa Wickman; Su Q Wang; Mahboob Chowdhury; Roger C Wiggins
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

Review 2.  Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.

Authors:  Daniel Seron; Marion Rabant; Jan Ulrich Becker; Candice Roufosse; Maria Irene Bellini; Georg A Böhmig; Klemens Budde; Fritz Diekmann; Denis Glotz; Luuk Hilbrands; Alexandre Loupy; Rainer Oberbauer; Liset Pengel; Stefan Schneeberger; Maarten Naesens
Journal:  Transpl Int       Date:  2022-05-20       Impact factor: 3.842

3.  Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.

Authors:  Maarten Naesens; Evelyne Lerut; Hylke de Jonge; Boudewijn Van Damme; Yves Vanrenterghem; Dirk R J Kuypers
Journal:  J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 10.121

4.  P2Y2 receptor deficiency aggravates chronic kidney disease progression.

Authors:  Sebastian A Potthoff; Johannes Stegbauer; Jan Becker; P Johannes Wagenhaeuser; Blanka Duvnjak; Lars C Rump; Oliver Vonend
Journal:  Front Physiol       Date:  2013-09-19       Impact factor: 4.566

5.  Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers After Renal Transplantation.

Authors:  Gerold Thölking; Nils Hendrik Gillhaus; Katharina Schütte-Nütgen; Hermann Pavenstädt; Raphael Koch; Barbara Suwelack; Stefan Reuter
Journal:  J Clin Med       Date:  2020-01-23       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.